1 天
Pharmaceutical Technology on MSNNeurona raises $102m to advance cell therapy for drug-resistant epilepsyNeurona will kick start a Phase III trial in H2 2025 investigating NRTX-1001 in patients with a type of drug-resistant ...
Epilepsy is a condition that affects the brain ... When the seizure has stopped, place them in the recovery position, offer reassurance and stay with them as they come round.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果